Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCEPT: Ustekinumab vs Etanercept in Plaque Psoriasis
NCT00454584Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 2007
- Primary completion
- Jan 2008
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of ustekinumab in plaque psoriasis, sponsored by Janssen Pharmaceutical. Started Mar 2007; status: completed.
02
Drugs
ustekinumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00454584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00454584.